FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895848679> ?p ?o ?g. }

• W2895848679 endingPage "7" @default.
• W2895848679 startingPage "1" @default.
• W2895848679 abstract "We have recently shown that the pyridinium aldoximes, best-known as therapeutic antidotes for chemical warfare nerve-agents, could markedly detoxify the carcinogenic tetrachloro-1,4-benzoquinone (TCBQ) via an unusual double Beckmann fragmentation mechanism. However, it is still not clear why pralidoxime (2-PAM) cannot provide full protection against TCBQ-induced biological damages even when 2-PAM was in excess. Here we show, unexpectedly, that TCBQ can also activate pralidoxime to generate a reactive iminyl radical intermediate in two-consecutive steps, which was detected and unequivocally characterized by the complementary application of ESR spin-trapping, HPLC/MS and nitrogen-15 isotope-labeling studies. The same iminyl radical was observed when TCBQ was substituted by other halogenated quinones. The end product of iminyl radical was isolated and identified as its corresponding reactive and toxic aldehyde. Based on these data, we proposed that the reaction of 2-PAM and TCBQ might be through the following two competing pathways: a nucleophilic attack of 2-PAM on TCBQ forms an unstable transient intermediate, which can decompose not only heterolytically to form 2-CMP via double Beckmann fragmentation, but also homolytically leading to the formation of a reactive iminyl radical in double-steps, which then via H abstraction and further hydrolyzation to form its corresponding more toxic aldehyde. Analogous radical homolysis mechanism was observed with other halogenated quinones and pyridinium aldoximes. This study represents the first detection and identification of reactive iminyl radical intermediates produced under normal physiological conditions, which provides direct experimental evidence to explain only the partial protection by 2-PAM against TCBQ-induced biological damages, and also the potential side-toxic effects induced by 2-PAM and other pyridinium aldoxime nerve-agent antidotes." @default.
• W2895848679 created "2018-10-26" @default.
• W2895848679 creator A5010459854 @default.
• W2895848679 creator A5011165903 @default.
• W2895848679 creator A5043807045 @default.
• W2895848679 creator A5044549205 @default.
• W2895848679 creator A5058532575 @default.
• W2895848679 creator A5081844561 @default.
• W2895848679 creator A5091122351 @default.
• W2895848679 date "2019-01-01" @default.
• W2895848679 modified "2023-10-17" @default.
• W2895848679 title "An unusual double radical homolysis mechanism for the unexpected activation of the aldoxime nerve-agent antidotes by polyhalogenated quinoid carcinogens under normal physiological conditions" @default.
• W2895848679 cites W1566956508 @default.
• W2895848679 cites W1970710349 @default.
• W2895848679 cites W1978788346 @default.
• W2895848679 cites W1980406629 @default.
• W2895848679 cites W1985431868 @default.
• W2895848679 cites W1987633665 @default.
• W2895848679 cites W2001020336 @default.
• W2895848679 cites W2002543880 @default.
• W2895848679 cites W2004895379 @default.
• W2895848679 cites W2005645371 @default.
• W2895848679 cites W2008270251 @default.
• W2895848679 cites W2025095151 @default.
• W2895848679 cites W2027310628 @default.
• W2895848679 cites W2027973177 @default.
• W2895848679 cites W2028801421 @default.
• W2895848679 cites W2029398242 @default.
• W2895848679 cites W2029669944 @default.
• W2895848679 cites W2035426198 @default.
• W2895848679 cites W2047840739 @default.
• W2895848679 cites W2053943424 @default.
• W2895848679 cites W2054296225 @default.
• W2895848679 cites W2061150572 @default.
• W2895848679 cites W2065532262 @default.
• W2895848679 cites W2065957780 @default.
• W2895848679 cites W2066010863 @default.
• W2895848679 cites W2066756161 @default.
• W2895848679 cites W2072286901 @default.
• W2895848679 cites W2081444345 @default.
• W2895848679 cites W2081767706 @default.
• W2895848679 cites W2090671578 @default.
• W2895848679 cites W2090990681 @default.
• W2895848679 cites W2095358649 @default.
• W2895848679 cites W2100112042 @default.
• W2895848679 cites W2119612457 @default.
• W2895848679 cites W2138702835 @default.
• W2895848679 cites W2148357975 @default.
• W2895848679 cites W2164613158 @default.
• W2895848679 cites W2171828940 @default.
• W2895848679 cites W2314714056 @default.
• W2895848679 cites W2343947509 @default.
• W2895848679 cites W2464831798 @default.
• W2895848679 cites W2513309801 @default.
• W2895848679 cites W2534274288 @default.
• W2895848679 cites W2704877788 @default.
• W2895848679 cites W2734142404 @default.
• W2895848679 cites W2766081272 @default.
• W2895848679 cites W2781702430 @default.
• W2895848679 cites W2953210714 @default.
• W2895848679 cites W69352207 @default.
• W2895848679 doi "https://doi.org/10.1016/j.freeradbiomed.2018.10.425" @default.
• W2895848679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30352302" @default.
• W2895848679 hasPublicationYear "2019" @default.
• W2895848679 type Work @default.
• W2895848679 sameAs 2895848679 @default.
• W2895848679 citedByCount "11" @default.
• W2895848679 countsByYear W28958486792019 @default.
• W2895848679 countsByYear W28958486792020 @default.
• W2895848679 countsByYear W28958486792021 @default.
• W2895848679 countsByYear W28958486792023 @default.
• W2895848679 crossrefType "journal-article" @default.
• W2895848679 hasAuthorship W2895848679A5010459854 @default.
• W2895848679 hasAuthorship W2895848679A5011165903 @default.
• W2895848679 hasAuthorship W2895848679A5043807045 @default.
• W2895848679 hasAuthorship W2895848679A5044549205 @default.
• W2895848679 hasAuthorship W2895848679A5058532575 @default.
• W2895848679 hasAuthorship W2895848679A5081844561 @default.
• W2895848679 hasAuthorship W2895848679A5091122351 @default.
• W2895848679 hasConcept C114246631 @default.
• W2895848679 hasConcept C139066938 @default.
• W2895848679 hasConcept C161790260 @default.
• W2895848679 hasConcept C175689099 @default.
• W2895848679 hasConcept C178790620 @default.
• W2895848679 hasConcept C178907741 @default.
• W2895848679 hasConcept C181199279 @default.
• W2895848679 hasConcept C185592680 @default.
• W2895848679 hasConcept C192937433 @default.
• W2895848679 hasConcept C2776327929 @default.
• W2895848679 hasConcept C2777221202 @default.
• W2895848679 hasConcept C2778816929 @default.
• W2895848679 hasConcept C75473681 @default.
• W2895848679 hasConceptScore W2895848679C114246631 @default.
• W2895848679 hasConceptScore W2895848679C139066938 @default.
• W2895848679 hasConceptScore W2895848679C161790260 @default.
• W2895848679 hasConceptScore W2895848679C175689099 @default.
• W2895848679 hasConceptScore W2895848679C178790620 @default.
• W2895848679 hasConceptScore W2895848679C178907741 @default.

• next